CKD-391 Pharmacokinetic Study Phase I
NCT02501200
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
CKD-391
DRUG:
Atrovastatin and Ezetimibe combination therapy
Sponsor
Chong Kun Dang Pharmaceutical